Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 2, 2010, Pages

  Canale Zambrano, Juan C ^a   Auger, Meagan L ^a   Haston, Christina K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cystic fibrosis; Intestinal obstruction; Survival; Toll like receptor 4

Indexed keywords

TOLL LIKE RECEPTOR 4; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; CYSTIC FIBROSIS; ENTEROPATHY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; ILEUM; INFLAMMATORY CELL; INTESTINE; INTESTINE MUCOSA; INTESTINE OBSTRUCTION; INTESTINE VILLUS; MAST CELL; MOUSE; MUTANT; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL; SURVIVAL RATE;

ANIMALS; ANIMALS, NEWBORN; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENOTYPE; HAPLOTYPES; ILEUM; INTESTINAL OBSTRUCTION; KAPLAN-MEIERS ESTIMATE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, MUTANT STRAINS; PHENOTYPE; TOLL-LIKE RECEPTOR 4;

EID: 77955605234     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00003.2010     Document Type: Article

References (48)

1. Blohmke CJ, Victor RE, Hirschfeld AF, Elias IM, Hancock DG, Lane CR, Wilcox PG, Smith KD, Overhage J, Hancock REW, Turvey SE. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J Immunol 180: 7764-7773, 2008.
2. Bradford EM, Sartor MA, Gawenis LR, Clarke LL, Shull GE. Reduced NHE3-mediated Na+ absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 296: G886-G898, 2009.
3. Campos MA, Rosinha GMS, Almeida IC, Salgueiro XS, Jarvis BW, Splitter GA, Qureshi N, Bruna-Romero O, Gazzinelli RT, Oliveira SC. Role of toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect Immun 72: 176-186, 2004. (Pubitemid 38018175)
4. Canale-Zambrano JC, Poffenberger MC, Cory SM, Humes DG, Haston CK. Intestinal phenotype of variable-weight cystic fibrosis knockout mice. Am J Physiol Gastrointest Liver Physiol 293: G222-G229, 2007.
5. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017, 2000. (Pubitemid 32463415)
6. Collins F. Cystic fibrosis: molecular biology and therapeutic implications (Abstract). Science v256: 774, 1992.
7. Davidson DJ, Rolfe M. Mouse models of cystic fibrosis. Trends Genet 17: S29-S37, 2001.
8. De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLoS One 4: e4283, 2009.
9. De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 293: G577-G584, 2007. (Pubitemid 47435389)
10. Fitzgerald KA, Chen ZJJ. Sorting out toll signals. Cell 125: 834-836, 2006.
11. Fukata M, Chen AL, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu RL, Inoue H, Arditi M, Dannenberg AJ, Abreu MT. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877, 2006. (Pubitemid 44316821)
12. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, Nast CC, Lechago J, Xu RL, Naiki Y, Soliman A, Arditi M, Abreu MT. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055-G1065, 2005. (Pubitemid 40563149)
13. Furuta T, Kikuchi T, Akira S, Watanabe N, Yoshikawa Y. Roles of the small intestine for induction of toll-like receptor 4-mediated innate resistance in naturally acquired murine toxoplasmosis. Int Immunol 18: 1655-1662, 2006.
14. Gallagher AM, Gottlieb RA. Proliferation, not apoptosis, alters epithelial cell migration in small intestine of CFTR null mice. Am J Physiol Gastrointest Liver Physiol 281: G681-G687, 2001.
15. Grubb BR, Gabriel SE. Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 273: G258-G266, 1997.
16. Hasegawa M, Osaka T, Tawaratsumida K, Yamazaki T, Tada H, Chen GY, Tsuneda S, Núñez G, Inohara N. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect Immun 78: 639-650, 2010.
17. Haston CK, Corey M, Tsui LC. Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice. Mamm Genome 13: 614-618, 2002. (Pubitemid 35398936)
18. Haston CK, Cory S, Lafontaine L, Dorion G, Hallett MT. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model. Physiol Genomics 25: 336-345, 2006.
19. Haston CK, Li W, Li A, Lafleur M, Henderson JE. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med 177: 309-315, 2008.
20. Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mamm Genome 13: 605-613, 2002.
21. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Gobel UB, Bereswill S. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948, 2007.
22. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 28: 623-667, 2010.
23. Jayawardana STM, Ushio H, Niyonsaba F, Gondokaryono SP, Takenaka H, Ikeda S, Okumura K, Ogawa H. Monomeric IgE and lipopolysaccharide synergistically prevent mast-cell apoptosis. Biochem Biophy Res Commun 365: 137-142, 2008.
24. Kent G, Oliver M, Foskett JK, Frndova H, Durie P, Forstner J, Forstner GG, Riordan JR, Percy D, Buchwald M. Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res 40: 233-241, 1996. (Pubitemid 26249675)
25. Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, Deng W, Finlay BB, Vallance BA. Toll-Like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun 74: 2522-2536, 2006.
26. Koller B, Kappler M, Latzin P, Gaggar A, Schreiner M, Takyar S, Kormann M, Kabesch M, Roos D, Griese M, Hartl D. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 181: 2753-2763, 2008.
27. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, Dubowski TD, Sodhi CP, Hackam DJ. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 179: 4808-4820, 2007.
28. Lynch 3rd JP. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion. Semin Respir Crit Care Med 30: 596-610, 2009.
29. Mann PB, Elder KD, Kennett MJ, Harvill ET. Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica. Infect Immun 72: 6650-6658, 2004.
30. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266, 2002.
31. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 72: 6040-6049, 2004.
32. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: G1032-G1041, 2004.
33. Obrien AD, Rosenstreich DL, Scher I, Campbell GH, Macdermott RP, Formal SB. Genetic control of susceptibility to Salmonella-Typhimurium in mice: role of the Lps gene. J Immunol 124: 20-24, 1980.
34. Ortega-Cava CF, Ishihara S, Rumi MAK, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y, Kinoshita Y. Strategic compartmentalization of toll-like receptor 4 in the mouse gut. J Immunol 170: 3977-3985, 2003.
35. Ott SJ, Musfeldt M, Ullmann U, Hampe J, Schreiber S. Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 42: 2566-2572, 2004.
36. Poltorak A, He XL, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
37. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis. Cell 118: 229-241, 2004.
38. Rodriguez D, Keller AC, Faquim-Mauro EL, de Macedo MS, Cunha FQ, Lefort J, Vargaftig BB, Russo M. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 171: 1001-1008, 2003.
39. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323, 2009.
40. Shang LM, Fukata M, Thirunarayanan N, Martin AP, Arnaboldi P, Maussang D, Berin C, Unkeless JC, Mayer L, Abreu MT, Lira SA. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 135: 529-538, 2008.
41. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH. An animal-model for cystic-fibrosis made by gene targeting. Science 257: 1083-1088, 1992.
42. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by toll-like receptor 4. J Immunol 167: 2250-2256, 2001.
43. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, Fang FC. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 172: 6202-6208, 2004.
44. Vogel SN, Wax JS, Perera PY, Padlan C, Potter M, Mock BA. Construction of a Balb/C congenic mouse, C.C3H-Lps(D), that expresses the Lps(D) allele: analysis of chromosome-4 markers surrounding the Lps gene. Infect Immun 62: 4454-4459, 1994.
45. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. London, UK: McGraw-Hill, 2009.
46. Yoshikawa H, Tasaka K. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation. Eur J Immunol 33: 2149-2159, 2003.
47. Young FD, Newbigging S, Choi C, Keet M, Kent G, Rozmahel RF. Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3. Gastroenterology 133: 1928-1937, 2007.
48. Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, Macek M, Langfelder-Schwind E, Marshall BC, Celie-Germana J, Claustres M, Palacio A, Bal J, Nowakowska A, Ferec C, Estivill X, Durie P, Tsui LC. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 22: 128-129, 1999.